Ronald Marston
Known title: DirectorCIK: 0001652392
Ronald Marston's purchase track record
Ronald Marston has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/12/2026 | XRN | $51K | +5.0% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| XRN | ▲ Buy | Open Market | 300 | $10K | 5/12/2026 | View on chart |
| XRN | ▲ Buy | Open Market | 1,011 | $34K | 5/12/2026 | View on chart |
| XRN | ▲ Buy | Open Market | 189 | $6K | 5/12/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Cantor Fitzgerald initiates Chiron Real Estate coverage with Overweight
Cantor Fitzgerald began covering Chiron Real Estate with an Overweight rating and a $43 price target. This new analyst view is notable because the current average target from eight analysts is $38.00. The company also offers a high dividend yield of 8.98%, which may be a factor in the new coverage initiation.
Cantor Fitzgerald initiates Chiron Real Estate coverage with Overweight. Cantor Fitzgerald began covering Chiron Real Estate with an Overweight rating and a $43 price target. This new analyst view is notable because the current average target from eight analysts is $38.00. The company also offers a high dividend yield of 8.98%, which may be a factor in the new coverage initiation.